Palisade Bio Inc (PALI): Congress and insider trades

Who in Congress and inside the company traded PALI, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Palisade Bio Inc (PALI) is a listed stock on NASDAQ.
  • Insiders filed 6 open market buys worth $250K and 2 sells worth $410K, the latest filed 2026-07-10 (10 July 2026).
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 0 0 members
Congress sells 0
Insider buys 6 $250K
Insider sells 2 $410K
Congress buys vs S&P, 90d n/a 0 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Insider trades in PALI

as of 2026-07-10
Open market insider trades in PALI, newest first.
FiledInsiderTypeSharesPriceValue90 day vs S&P
10 Jul 2026 Baltera Robert Jr. buy 25,000 $1.96 $48.9K n/a
10 Jul 2026 Baltera Robert Jr. buy 20,000 $1.99 $39.8K n/a
8 Jul 2026 Jones Mitchell Lawrence sell 51,880 $2.05 $107K n/a
8 Jul 2026 Baltera Robert Jr. buy 30,000 $2.03 $61.0K n/a
8 Jul 2026 Finley John David sell 146,798 $2.07 $303K n/a
8 Jul 2026 Baltera Robert Jr. buy 20,000 $2.05 $41.0K n/a
6 Jul 2026 Baltera Robert Jr. buy 10,000 $1.98 $19.8K n/a
6 Jul 2026 Baltera Robert Jr. buy 20,000 $1.98 $39.6K n/a

Frequently asked questions

Who has bought PALI?

0 Congress buys by 0 members and 6 insider buys are on file. The tables on this page list every one.

Did buying PALI after a disclosure beat the market?

No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.